The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...
Three out of four adults in the United States live with conditions that can increase the risk of severe illness. 9 Chronic ...
A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could ...
A Washington resident has been hospitalized with bird flu, according to the Washington State Health Department, and they’re ...
Multiple people across the globe who stepped forward are speaking about what they say is the debilitating aftermath they now ...
More than 3,500 cases of pertussis, or whooping cough, cases have been reported in Texas so far this year, already reaching a ...
Discovered COVID Vaccine Side Effect. There's a potentially new incentive to get vaccinated and boosted: A University of ...
DelveInsight's Oropharyngeal Cancer Market Insights report includes a comprehensive understanding of current treatment ...
Hosted on MSN
Should You Buy Moderna Right Now?
Moderna may look appealing right now, given the company's high cash balance and extensive drug pipeline. However, as Moderna's cash burn dilemma persists, the company's net value will likely keep ...
CAMBRIDGE, MA / ACCESS Newswire / October 22, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the Company's ...
Moderna Inc. said its vaccine to prevent cytomegalovirus, a common cause of birth defects, failed to meet its goal in a late-stage trial, a setback for the company still struggling to move past the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback